Yvett Pinedo

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

Chloe Orkin, Jean‐Michel Molina, Pedro Cahn et al. · The Lancet HIV · 2023 · 32 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Microscopic Observation Drug Susceptibility Assay for Tuberculosis Screening before Isoniazid Preventive Therapy in HIV‐Infected Persons

Krishna P. Reddy, Mark F. Brady, Robert H. Gilman et al. · Clinical Infectious Diseases · 2010 · 31 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Pharmacology +7

Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Antiretroviral-Experienced Subjects: Week 48 Analysis of AI438011, a Phase IIb, Randomized Controlled Trial

Melanie Thompson, Jacob Lalezari, Richard Kaplan et al. · Antiviral Therapy · 2016 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV

Lerato Mohapi, Yvett Pinedo, Olayemi Osiyemi et al. · AIDS · 2021 · 28 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

Ruth Lynfield, Marcelo Losso, Richard T. Davey et al. · Open Forum Infectious Diseases · 2017 · 18 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +6